Milano, 26 febbraio 2016
Scarica il programma in formato PDF
Virtual meeting con la registrazione audio degli interventi
Session I – Pharmacological bases
- Development and evolution of the Concept
R. Kerbel (Toronto, Canada) - Mechanisms of Action and Preclinical Activity: agents used in mCT
E. Pasquier (Marseille, France) - Pharmacokinetics, Pharmacodynamics and Pharmacogenetics
G. Bocci (Pisa) - Immunotherapy and metronomic therapy
R. Danielli (Siena)
Session II – Clinical Activity
- Breast cancer
M. Colleoni (Milan) - Lung cancer
A. Camerini (Lido di Camariore) - Gastrointestinal cancers
L. Salvatore (Pisa)
Session III – Clinical Practice
- Clinical Case
A. Milano (Rome) - Clinical Case
M.V. Dieci (Padova) - Clinical Case
M. Pagano (Reggio Emilia) - Adverse side effects associated to metronomic chemotherapy
E. Munzone (Milan)
